I agree with you that the word is overused. Avastin is most certainly not a breakthrough, I don't know any oncologist that considers it as such.
I think the word is justified in this context however because the rationale behind immunotherapy is very sound, and it seems able to cure a non-negligible proportion of patients with otherwise incurable disease.